MedX Holdings Inc (MEDH) Fair Value & Analysis
Consumer Defensive · US · Market cap $1.2M
MedX Holdings Inc
MEDH · US
Fair value as of: Aug 15, 2026
From 15 valuation models · updated 3 days ago
Fair value updated Aug 15, 2026, revised from $0.0024 to $0.0018 (−24.1%) since Jul 31, 2026. Share price −22.2% over the past month.
Below-average quality, screening 29% undervalued on our models.
What matters now
- The price is below even our cautious bear case ($0.0018). The market is more pessimistic than our downside scenario.
- Solid quality (47/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 15, 2026.
How to read this chart
60‑month range $0.0001 – $0.0110 · the $0.0014 price screens below the $0.0018 fair value. Dashed = 300-day average. As of Aug 15, 2026.
Analysis
MedX Holdings Inc (MEDH) currently trades at $0.0014, while our model-based Fair Value estimate is $0.0018, implying the stock looks roughly 28.6% undervalued today. The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, MedX Holdings Inc generated revenue of $1.1M at a net margin of 1.6%. Revenue declined 70.2% year over year. Net debt stands at $4.8M. Fundamentals as of Aug 15, 2026
The share trades about 36% below its 52-week high and 367% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 6% fair-value upside, at 29%, MEDH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: Growth Earnings ($0.0200) versus DCF Models ($0.0100). Highest evidence: Residual Income (76).
Notify me when MEDH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 15, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 63
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2018 – FY2025 · reported fiscal years
MedX Holdings Inc reported revenue of $1.8M in FY2025 versus $2.2M in FY2018, a compound −3.0%/yr. Reported net income was $269K in FY2025.
Watch MEDH: get an alert when its fair value changes →
Peer Group
Tobacco · 36 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Tobacco median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 20/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Aug 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Philip Morris International Inc PM | $186.19 | $103.71 | -44% |
| British American Tobacco p.l.c. BTI | $55.84 | $61.07 | +9% |
| Altria Group MO | $64.38 | $81.81 | +27% |
| KT&G Corporation 033780 | 177,400 KRW | 110,656 KRW | -38% |
| PT Hanjaya Mandala Sampoerna Tbk, HMSP | 730.00 IDR | 1,041 IDR | +43% |
| Smoore International Holdings 6969 | HK$8.76 | HK$4.19 | -52% |
| Godfrey Phillips India Limited GODFRYPHLP | ₹2,160 | ₹1,194 | -45% |
| PT Gudang Garam Tbk, GGRM | 19,575 IDR | 16,988 IDR | -13% |
| TABAK TABAK | 18,700 CZK | 23,215 CZK | +24% |
| China Tobacco International (HK) Company 6055 | HK$22.82 | HK$24.09 | +6% |
Compare MedX Holdings Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is MedX Holdings Inc (MEDH) overvalued or undervalued?
What is the fair value of MEDH?
What is the quality score of MEDH?
What is the revenue of MedX Holdings Inc (MEDH)?
What is the net profit margin of MEDH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track MedX Holdings Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.